Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Full year trading statement

10 Jan 2025 07:00

RNS Number : 8294S
Anpario PLC
10 January 2025
 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 

 

Anpario plc("Anpario", the "Group" or the "Company")

 

Full year trading statement

 

Anpario plc (AIM:ANP), the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, provides the following trading update for the year ended 31 December 2024 ("FY 2024"). The figures set out in this announcement remain subject to audit.

 

Trading update

The Group, including three months of trading for Bio-Vet Inc., delivered a stronger than expected operating performance in the second half of 2024. Year-end sales were higher than anticipated, and the Group now expects revenue for the 12 months ended 31 December 2024 to be approximately £37.5m* (31 December 2023: £31.0m). This strong performance in revenue combined with the Group's high operational gearing and favourable year-end foreign exchange movements, will result in adjusted EBITDA being ahead of current market expectations*.

 

Bio-Vet Inc. had a strong final quarter due to heightened demand for its products, which support the health of dairy cows affected by avian influenza, and our Middle East and Africa segment delivered an outstanding sales performance.

 

Financial position

Our financial position remains strong, with year-end cash balances of £10.5m* (31 December 2023: £10.6m), after accounting for the acquisition of Bio-Vet Inc. and associated land and buildings for an initial cash consideration of US$6.3m, on a debt-free basis, which completed in September 2024.

 

Our strong balance sheet enables the Group to invest in innovative natural product solutions, expand our global reach and explore earnings enhancing and complementary acquisitions to continue the profitable development of the Group. We remain confident in our ability to capitalise on growth opportunities, delivering long-term benefits to all stakeholders.

 

FY2024 Results

The Group expects to publish its FY 2024 final results on or around 26 March 2025.

 

 

 

*Analyst consensus for FY 2024 immediately prior to this announcement was Revenue of £35.25m, EBITDA of £5.7m and net cash of £7.2m.

 

Enquiries

 

Anpario plc

Richard Edwards, Chief Executive Officer

+44(0)7776 417 129

Marc Wilson, Group Finance Director

+44(0)1909 537 380

Shore Capital

 

(Nominated Adviser and Broker)

+44 (0) 20 7408 4090

Stephane Auton

Corporate Advisory

David Coaten

Tom Knibbs

Henry Willcocks

Corporate Broking

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUUUGUPAPWB
Date   Source Headline
19th Sep 20137:00 amBUSHalf-yearly Report
28th Jun 20137:00 amRNSGrant of Share Options
27th Jun 20131:59 pmBUSResult of AGM
27th Jun 20137:00 amBUSTrading Statement
10th Jun 20133:39 pmBUSEmployee Share Plan and Director's Dealing
8th May 20137:00 amRNSPosting of Annual Report and Issue of Equity
17th Apr 20137:00 amBUSFinal Results
1st Feb 20137:00 amBUSTrading Statement
24th Dec 201211:04 amBUSDirector/PDMR Shareholding
30th Nov 20127:00 amBUSDirector/PDMR Shareholding
8th Nov 20129:10 amBUSHolding(s) in Company
2nd Nov 20121:34 pmBUSTransaction in Own Shares
19th Sep 20127:00 amBUSHalf-yearly Report
10th Sep 20124:11 pmBUSHolding(s) in Company
3rd Sep 20129:59 amRNSHolding(s) in Company
3rd Sep 20129:57 amRNSHolding(s) in Company
17th Jul 20124:33 pmBUSHolding(s) in Company
28th Jun 20125:04 pmBUSPosting of Annual Report and Accounts
26th Jun 201211:09 amBUSAGM Statement
26th Jun 20127:00 amBUSTrading Statement
15th Jun 20122:14 pmBUSDirectorate Change
26th Apr 20127:00 amBUSFinal Results
30th Mar 20127:00 amBUSAcquisition
16th Mar 20122:40 pmBUSNotification of Change in Details of Directorships
12th Mar 20121:56 pmBUSHolding(s) in Company
1st Feb 20127:00 amBUSTrading Statement
12th Jan 20122:11 pmBUSDirector/PDMR Shareholding
21st Dec 201111:34 amBUSHolding(s) in Company
20th Dec 20115:02 pmBUSHolding(s) in Company
12th Dec 20111:00 pmBUSDirector/PDMR Shareholding
1st Dec 20117:00 amBUSChange of Name
30th Nov 20114:00 pmBUSChange of Name
17th Nov 20113:01 pmRNSHolding(s) in Company
17th Nov 20113:01 pmRNSHolding(s) in Company
1st Nov 20117:00 amBUSChange of Name
24th Oct 20113:39 pmRNSExercise of Share Options & Total Voting Rights
12th Oct 20117:00 amBUSHolding(s) in Company
6th Oct 201110:52 amBUSDirector/PDMR Shareholding
29th Sep 20112:48 pmBUSHolding(s) in Company
29th Sep 201110:31 amBUSDirector/PDMR Shareholding
27th Sep 20113:25 pmBUSDirector/PDMR Shareholding
15th Sep 20117:00 amBUSHalf-yearly Report
4th Aug 20117:00 amBUSTrading Statement
30th Jun 201111:46 amRNSAGM Statement
30th Jun 20117:00 amBUSTrading Statement
12th Apr 20117:00 amBUSFinal Results
1st Mar 20117:00 amBUSHolding(s) in Company
25th Feb 20111:45 pmRNSTotal Voting Rights & Holding(s) in Company
8th Feb 20117:20 amBUSKiotech International plc Performance Update 2011
4th Feb 20117:48 amBUSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.